Us Bancorp \De\ Rocket Pharmaceuticals, Inc. Transaction History

Us Bancorp \De\

$77.3 Billion
Q3 2024

A detailed history of Us Bancorp \De\ transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Us Bancorp \De\ holds 852 shares of RCKT stock, worth $8,698. This represents 0.0% of its overall portfolio holdings.

Number of Shares

852

Previous 1,082 21.26%

Holding current value

$8,698

Previous $23,000 34.78%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$17.6 - $25.88 $4,048 - $5,952	-230 Reduced 21.26%	852 $15,000
Q2 2024 Aug 06, 2024	SELL	$20.66 - $26.72 $22,622 - $29,258	-1,095 Reduced 50.3%	1,082 $23,000
Q1 2024 May 07, 2024	SELL	$26.16 - $30.74 $109,610 - $128,800	-4,190 Reduced 65.81%	2,177 $58,000
Q4 2023 Feb 09, 2024	SELL	$16.78 - $31.94 $53,595 - $102,016	-3,194 Reduced 33.41%	6,367 $190,000
Q3 2023 Nov 03, 2023	BUY	$15.07 - $24.05 $124,026 - $197,931	8,230 Added 618.33%	9,561 $195,000
Q2 2023 Aug 09, 2023	BUY	$16.59 - $23.6 $1,874 - $2,666	113 Added 9.28%	1,331 $26,000
Q1 2023 May 09, 2023	BUY	$15.79 - $22.6 $473 - $678	30 Added 2.53%	1,218 $20,000
Q4 2022 Feb 13, 2023	SELL	$15.5 - $22.76 $1,410 - $2,071	-91 Reduced 7.11%	1,188 $23,000
Q3 2022 Oct 27, 2022	SELL	$12.37 - $18.41 $4,280 - $6,369	-346 Reduced 21.29%	1,279 $20,000
Q2 2022 Aug 01, 2022	SELL	$7.96 - $16.64 $68,925 - $144,085	-8,659 Reduced 84.2%	1,625 $22,000
Q1 2022 May 11, 2022	BUY	$13.16 - $23.68 $15,134 - $27,232	1,150 Added 12.59%	10,284 $164,000
Q4 2021 Feb 11, 2022	BUY	$21.52 - $36.02 $28,922 - $48,410	1,344 Added 17.25%	9,134 $199,000
Q3 2021 Nov 10, 2021	BUY	$27.42 - $48.97 $52,152 - $93,140	1,902 Added 32.3%	7,790 $233,000
Q2 2021 Aug 05, 2021	BUY	$39.41 - $47.25 $31,961 - $38,319	811 Added 15.97%	5,888 $261,000
Q1 2021 Apr 28, 2021	BUY	$43.34 - $65.91 $208,985 - $317,818	4,822 Added 1890.98%	5,077 $225,000
Q4 2020 Feb 04, 2021	BUY	$23.3 - $59.57 $3,308 - $8,458	142 Added 125.66%	255 $14,000
Q3 2020 Nov 10, 2020	BUY	$20.5 - $28.59 $2,316 - $3,230	113 New	113 $3,000

Others Institutions Holding RCKT

# of Institutions

210

Shares Held

93.3M

Call Options Held

319K

Put Options Held

70.3K

View Full List

About ROCKET PHARMACEUTICALS, INC.

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $773M
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

More about RCKT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account